U

University of Malaya Medical Centre | Department of Rheumatology

Research site
(Unclaimed)
Location
CIC Menara Timur UMMC, Kuala Lumpur, Selangor, Malaysia
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

11 of 49
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms (VITALISScE™)

This study is open to adults aged 18 and older or above legal age who have systemic sclerosis. People can participate if they have a specific subtype...

Enrolling
Scleroderma, Systemic
Drug: Placebo
Drug: Avenciguat (BI 685509)

This study is open to adults with schizophrenia who took part in a previous CONNEX study (study 1346-0011, 1346-0012, or 1346-0013). The purpose of t...

Enrolling
Schizophrenia
Drug: Iclepertin

This study is open to adults with head and neck cancer or liver cancer. This is a study for people for whom previous treatment was not successful or...

Active, not recruiting
Head and Neck Squamous Cell Carcinoma (HNSCC)
Drug: Cetuximab
Other: Investigator´s Choice Chemotherapy

This study is open to adults with schizophrenia. Schizophrenia can affect the way a person thinks, their memory and their mental functioning. Example...

Enrolling
Schizophrenia
Drug: Placebo
Drug: Iclepertin

D²EFT is a randomised, open-label study in HIV-1 infected patients failing first-line antiretroviral therapy (ART). The study compares 2 regimens of...

Active, not recruiting
HIV Infections
Drug: Darunavir
Drug: NRTIs

Double-blind, randomized, placebo-controlled, Phase 3 study to investigate the efficacy and safety of odevixibat compared to placebo in children with...

Enrolling
Biliary Atresia
Drug: Odevixibat
Drug: Placebo

The primary aim of the study is to investigate the effect of empagliflozin on kidney disease progression or cardiovascular death versus placebo on to...

Active, not recruiting
Chronic Kidney Disease
Drug: Matching placebo
Drug: Empagliflozin

A Phase II/III Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection...

Enrolling
SARS-CoV-2 Infection
Drug: Placebo
Drug: Azvudine

This study will evaluate the safety and efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive...

Enrolling
Nasopharyngeal Carcinoma
EBV-Related Sarcoma
Drug: Valganciclovir
Drug: Nanatinostat

Objectives:Primary: To demonstrate the safety of allogeneic UC-MSCs administered by injection for complex perianal fistulas in patients with Crohn's...

Enrolling
Fistula in Ano
Perianal Fistula Due to Crohn's Disease
Biological: PF2020-CELL (UC-MSCs) - Allogeneic Human Umbilical Cord Mesenchymal Stem Cells

The TRACK trial is an investigator-initiated, multicentre, prospective, randomised, quadruple-blind (participant, healthcare provider, data collector...

Enrolling
Chronic Kidney Diseases
Dialysis-dependent Kidney Failure
Drug: Rivaroxaban 2.5 Mg Oral Tablet
Other: Placebo

Trial conditions

Kidney Diseases (6 trials)
Chronic Renal Insufficie... (4 trials)
Critical Illness (3 trials)
Infections (3 trials)
Carcinoma (2 trials)
Cardiovascular Diseases (2 trials)
Dengue (2 trials)
Fatty Liver (2 trials)
Leukemia (2 trials)
Lymphoid Leukemia (2 trials)

And 64 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems